1-15 of 15
Sandrine Niyongere
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed/refractory acute myeloid leukemia

Clinical Trials & Observations
Yuchen Liu, Dominique R Bollino, Osman M Bah, Erin T Strovel, Tien Van Le, Jinoos Zarrabi, Sunita Philip, Rena G Lapidus, Maria R Baer, Sandrine Niyongere, Vu H. Duong, Christine C Dougherty, Jan Hendrik Beumer, Katherine D Caprinolo, Farin Kamangar, Ashkan Emadi
Journal: Blood
Blood blood.2024024837.
https://doi.org/10.1182/blood.2024024837
Published: 2024
Includes: Supplemental data
Journal Articles

Overcoming Venetoclax (Ven) Resistance through Glutamine (Gln) Depletion: Final Analysis of the Phase 1 Trial of Ven and Pegcrisantaspase (PegC) Combination in Relapsed and Refractory (R/R) Acute Myeloid Leukemia (AML)

Yuchen Liu, Dominique Bollino, Osman M Bah, Erin T Strovel, Jinoos Zarrabi, Sunita Philip, Ezzat Mostafa, Rena G Lapidus, Maria R. Baer, Sandrine Niyongere, Vu H. Duong, Christine C Dougherty, Katherine Caprinolo, Ashkan Emadi
Journal: Blood
Blood (2023) 142 (Supplement 1): 60.
https://doi.org/10.1182/blood-2023-186244
Published: 2023
Journal Articles

Phase 1 Dose Escalation Trial of Pegcrisantaspase in Combination with Venetoclax in Adults with Relapsed or Refractory Acute Myeloid Leukemia

Dominique R Bollino, Yuchen Liu, Osman Mohamed Bah, Katherine Caprinolo, Jinoos Zarrabi, Sunita Philip, Ezzat Mostafa, Rena G. Lapidus, Zeba Singh, Michael Kallen, Yi Ning, Rima Koka, Maria R. Baer, Sandrine Niyongere, Vu H. Duong, Erin T Strovel, Molly Graveno, Ashkan Emadi
Journal: Blood
Blood (2022) 140 (Supplement 1): 9044–9045.
https://doi.org/10.1182/blood-2022-159621
Published: 2022
Journal Articles

Outcomes of Newly Diagnosed Therapy-Related AML and AML with Myelodysplasia-Related Changes Treated with 7+3, Hypomethylating Agents with or without Venetoclax and CPX-351: A Retrospective Cohort Study

Hanan Alharthy, Fahad Alkaabba, Matthew Williams, Elizabeth Corley, Kathryn A.F. Kline, Jennie Y. Law, Seung Tae Lee, Sandrine Niyongere, Vu H. Duong, Maria R. Baer, Moaath K. Mustafa Ali
Journal: Blood
Blood (2022) 140 (Supplement 1): 9025–9026.
https://doi.org/10.1182/blood-2022-170688
Published: 2022
Journal Articles

Prognostication of the 2016-Who AML with Myelodysplasia-Related Changes Subclass and Mutations in MDS-Related Genes Using the 2022 European Leukemianet Risk Classification: A Retrospective Study

Fahad Alkaabba, Matthew Williams, Elizabeth Corley, Hanan Alharthy, Kathryn A.F. Kline, Seung Tae Lee, Michael Kallen, Sandrine Niyongere, Vu H. Duong, Maria R. Baer, Moaath K. Mustafa Ali
Journal: Blood
Blood (2022) 140 (Supplement 1): 3237–3238.
https://doi.org/10.1182/blood-2022-170531
Published: 2022
Journal Articles

The Impact of IDH1c.315C>T Single Nucleotide Polymorphism on Outcomes in Acute Myeloid Leukemia: A Propensity Score-Adjusted Cohort Study

Elizabeth Corley, Moaath Mustafa Ali, Hanan Alharthy, Kathryn Kline, Danielle Sewell, Jennie Y. Law, Seung Tae Lee, Sandrine Niyongere, Vu H. Duong, Maria R. Baer, Ashkan Emadi
Journal: Blood
Blood (2021) 138 (Supplement 1): 4454.
https://doi.org/10.1182/blood-2021-151651
Published: 2021
Journal Articles

Pegcrisantaspase in Combination with Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: A Phase 1 Study

Sandrine Niyongere, Vu H. Duong, Dominique R Bollino, Rena G. Lapidus, Erin T. Strovel, Jinoos Zarrabi, Osman Mohamed Bah, Sunita Philip, Veronica Kflu, Maria R. Baer, Ashkan Emadi
Journal: Blood
Blood (2021) 138 (Supplement 1): 4433.
https://doi.org/10.1182/blood-2021-150728
Published: 2021
Journal Articles

Hypomethylating Agent Therapy for Chronic Myelomonocytic Leukemia Does Not Impact Acute Myeloid Leukemia Transformation or Survival

Sandrine Niyongere, MD, Yamini Kathari, MD, Zeba Singh, MD, Emily J. Vannorsdall, MD, Ashkan Emadi, MD, PhD, Vu Doung, MD, M.S., Maria R. Baer, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 6–7.
https://doi.org/10.1182/blood-2020-142747
Published: 2020
Journal Articles

Phase 1/1b Trial of Talazoparib and Gemtuzumab Ozogamicin in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia

Amanda Przespolewski, DO, Elizabeth A. Griffiths, MD, James E. Thompson, MD, Amro Elshoury, MBBChir, Ashkan Emadi, MD, PhD, Vu H. Duong, MD, Sandrine Niyongere, MD, Wendy Walinski, Meriem Said, Stephanie Halliwell, Kemji Eke, Kristopher Attwood, PhD, Maria R. Baer, MD, Eunice S. Wang, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 20–21.
https://doi.org/10.1182/blood-2020-141736
Published: 2020
Journal Articles

Impact of Cardiovascular Disease on Clinical Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

Gabriela Sanchez-Petitto, MD, Olga Goloubeva, PhD MSc, James Childress, MD, Tahreem Iqbal, MD, Jack Masur, MD, Max An, BS, Safwan Muhammad, MD, Justin Lawson, PharmD BCOP, Jasmin Sahbaz, MD, Brian Barr, MD, Vu H. Duong, MD, Jennie Y. Law, MD, Ashkan Emadi, MD, PhD, Maria R. Baer, MD, Sandrine Niyongere, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-138534
Published: 2020
Journal Articles

PP2A Activators Enhance Efficacy of FLT3 Inhibitors in FLT3-ITD Acute Myeloid Leukemia Cells through AKT Inactivation-Dependent Pim-1 and c-Myc Proteasomal Degradation

Mario Scarpa, PhD, Prerna Singh, MS, Shivani Kapoor, MS, Jonelle K. Lee, MS, Sandrine Niyongere, MD, Goutham Narla, MD PhD, Danilo Perrotti, MD PhD, Maria R. Baer, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1276.
https://doi.org/10.1182/blood-2019-129011
Published: 2019
Journal Articles

Promising Results of a Phase 1/2 Clinical Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia

Eric Padron, MD, Amy E. DeZern, MD, Sandrine Niyongere, MD, Markus Christian Ball, PhD, Maria Balasis, Hanadi Ramadan, BA, Jeffrey E. Lancet, MD, Alan F List, MD, Ruben A Mesa, MD, Gail J. Roboz, MD, David P. Steensma, MD, Mikkael A. Sekeres, MD MS, Rami S. Komrokji, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 162.
https://doi.org/10.1182/blood.V130.Suppl_1.162.162
Published: 2017
Journal Articles

Robust patient-derived xenografts of MDS/MPN overlap syndromes capture the unique characteristics of CMML and JMML

Akihide Yoshimi, Maria E. Balasis, Alexis Vedder, Kira Feldman, Yan Ma, Hailing Zhang, Stanley Chun-Wei Lee, Christopher Letson, Sandrine Niyongere, Sydney X. Lu, Markus Ball, Justin Taylor, Qing Zhang, Yulong Zhao, Salma Youssef, Young Rock Chung, Xiao Jing Zhang, Benjamin H. Durham, Wendy Yang, Alan F. List, Mignon L. Loh, Virginia Klimek, Michael F. Berger, Elliot Stieglitz, Eric Padron, Omar Abdel-Wahab
Journal: Blood
Blood (2017) 130 (4): 397–407.
https://doi.org/10.1182/blood-2017-01-763219
Published: 2017
Includes: Supplemental data
Journal Articles

Comprehensive Inflammatory Cytokine Profiling Identifies IL-8/CXCL8 As Elevated, Associated with Proliferative Features, and Independently Prognostic in Chronic Myelomonocytic Leukemia (CMML)

Sandrine Niyongere, MD, Nolwenn Lucas, Samir Sansil, Christopher L Cubitt, PhD, Maria E. Balasis, Jodi Kroeger, Qing Zhang, MD, John J Ceremsak, Elliot Stieglitz, MD, YuLong Zhao, PhD, Markus Ball, PhD, Rami S. Komrokji, MD, Alan F List, MD, Valeria Santini, MD, Eric Solary, Eric Padron, MD
Journal: Blood
Blood (2016) 128 (22): 109.
https://doi.org/10.1182/blood.V128.22.109.109
Published: 2016
Journal Articles

Hemojuvelin Mutations in Whites, Blacks and Asians with Primary Iron Overload and in Control Subjects.

Pauline L. Lee, James C. Barton, David J. Brandhagen, Sandrine Niyongere, Sean Bohannon, Charles A. Rivers, Ronald A. Acton, Ernest Beutler
Journal: Blood
Blood (2004) 104 (11): 3198.
https://doi.org/10.1182/blood.V104.11.3198.3198
Published: 2004